Observation of the Effect of Biofeedback Electrical Stimulation Combined with WAFF Exercise in the Treatment of Uterine Scar Diverticulum
Objective:To explore the clinical effect of piperacillin tazobactam combined with salmeterol and flutica-sone on acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods:From January 2022 to Janu-ary 2024,100 COPD in acute exacerbation admitted to the emergency medicine department of Zhanjiang Central People's Hospital were studied and separated into the control group(n=50,piperacillin and tazobactam)and the observation group(n=50,salmeterol and fluticasone+piperacillin and tazobactam).The clinical therapeutic effect,pulmonary function and changes of inflammatory factors were compared.Results:The observation group had higher clinical therapeutic effect than the other group,better pulmonary function indexes after treatment,and lower levels of inflammatory indexes IL-6、hs-CRP and TNF-α(P<0.05).Conclusion:Piperacillin-tazobactam+salmeterol-fluticasone in acute exacerbation of COPD can improve the overall curative effect,improve the lung function index,reduce inflammatory factor levels and be beneficial to the prognosis.
Piperacillin and tazobactamSalmeterol and fluticasoneAcute exacerbation of chronic obstructive pul-monary diseasePulmonary function